Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer
Abstract The objective of this study was to determine the proportion of phase 3 clinical trials investigating a systemic therapy for patients with prostate, breast, lung, or colorectal cancer that excluded patients with Chronic Kidney Disease (CKD) and the exclusion criteria chosen, if any. A search...
Saved in:
| Main Authors: | Matthieu Delaye, Adrien Rousseau, Mélanie Try, Christophe Massard, Luca Campedel, Marc Hilmi, Corinne Bagnis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-02-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.5171 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Machine Learning for Monoclonal Gammopathies of Renal Significance Risk Stratification Using Clinical and Pathology Data
by: Giorgio Cazzaniga, et al.
Published: (2025-08-01) -
Immune checkpoint inhibitor-related myocarditis in patients with lung cancer
by: Wenli Cao, et al.
Published: (2025-04-01) -
Daptomycin in treatment of Gram-positive infections in children with hematological disorders
by: Z. M. Dyshlevaya, et al.
Published: (2012-05-01) -
Miniaturized FISH for screening of onco-hematological malignancies
by: Andrea Zanardi, et al.
Published: (2010-07-01) -
Changes of endotracheal tube cuff pressure and its indicators in laparoscopic resection of colorectal neoplasms: an observational prospective clinical trial. comment on: BMC anesthesiology. 2024 Nov 13;24(1):413
by: Andrew Maxwell
Published: (2025-04-01)